CARGO Therapeutics, Inc. Common Stock

NAS:CRGXHealthcare

——At close · Market cap —

CRGX · Cash flow · TradingHolo

USD millions	FY2021	FY2022	FY2023	FY2024	YoY
Net income	(5.9)	(41.0)	(98.1)	(167.5)	−70.7%
Depreciation & amortization	0.1	1.4	3.7	7.1	+91.6%
Stock-based compensation	0.5	0.3	3.3	18.0	+440.2%
Change in working capital	0.3	3.0	2.2	5.8	+161.4%
Operating cash flow	(4.9)	(29.1)	(81.2)	(139.7)	−72.2%
Capital expenditure	(0.4)	(3.3)	(9.0)	(4.4)	+50.5%
Acquisitions	0.0	0.0	0.0	0.0	—
Investing cash flow	(0.4)	(3.3)	(9.0)	(305.1)	−3292.8%
Dividends paid	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	28.5	3.5	0.0	−100.0%
Financing cash flow	5.4	34.2	494.6	103.5	−79.1%
Free cash flow	(5.4)	(32.4)	(90.2)	(144.2)	−59.9%
Net change in cash	0.0	1.8	404.4	(341.4)	−184.4%

USD millionsUpdated 8 May 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.